Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lauriane Filliatre

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
F1000Research|March 26, 2019
Recent advances in the first-line treatment of follicular non-Hodgkin lymphomaPierre Feugier, Lauriane Filliatre-Clement
Leukemia & Lymphoma|October 28, 2014
Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter studyIsabelle Fleury, Sandy Amorim, Nicolas Mounier, et al.
Hematological Oncology|August 15, 2018
Serum albumin or body mass index: Which prognostic factor for survival in patients with acute myeloblastic leukaemia?Lauriane Filliatre-Clement, Julien Broseus, Marc Muller, et al.
Hematological Oncology|May 4, 2018
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomesLauriane Filliatre-Clement, Delphine Maucort-Boulch, Estelle Bourbon, et al.
Oncotarget|November 22, 2017
Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CTCédric Rossi, Morgane Mounier, Pauline Brice, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
F1000Research|March 26, 2019
Recent advances in the first-line treatment of follicular non-Hodgkin lymphomaPierre Feugier, Lauriane Filliatre-Clement
Leukemia & Lymphoma|October 28, 2014
Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter studyIsabelle Fleury, Sandy Amorim, Nicolas Mounier, et al.
Hematological Oncology|August 15, 2018
Serum albumin or body mass index: Which prognostic factor for survival in patients with acute myeloblastic leukaemia?Lauriane Filliatre-Clement, Julien Broseus, Marc Muller, et al.
Hematological Oncology|May 4, 2018
Refractory diffuse large B-cell lymphoma after first-line immuno-CT: Treatment options and outcomesLauriane Filliatre-Clement, Delphine Maucort-Boulch, Estelle Bourbon, et al.
Oncotarget|November 22, 2017
Infradiaphragmatic Hodgkin lymphoma: a large series of patients staged with PET-CTCédric Rossi, Morgane Mounier, Pauline Brice, et al.
Pageof 1